Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) Current Deferred Revenue: 2014-2023

Historic Current Deferred Revenue for Cellectis (CLLS) over the last 2 years, with Sep 2023 value amounting to $59,000.

  • Cellectis' Current Deferred Revenue fell 53.91% to $59,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $59,000, marking a year-over-year decrease of 53.91%. This contributed to the annual value of $59,000 for FY2022, which is N/A change from last year.
  • As of Q3 2023, Cellectis' Current Deferred Revenue stood at $59,000, which was down 67.22% from $180,000 recorded in Q2 2023.
  • In the past 5 years, Cellectis' Current Deferred Revenue ranged from a high of $278,000 in Q1 2023 and a low of $59,000 during Q4 2022.
  • In the last 2 years, Cellectis' Current Deferred Revenue had a median value of $128,000 in 2022 and averaged $140,800.
  • Data for Cellectis' Current Deferred Revenue shows a maximum YoY crashed of 53.91% (in 2023) over the last 5 years.
  • Quarterly analysis of 2 years shows Cellectis' Current Deferred Revenue stood at $59,000 in 2022, then plummeted by 53.91% to $59,000 in 2023.
  • Its Current Deferred Revenue stands at $59,000 for Q3 2023, versus $180,000 for Q2 2023 and $278,000 for Q1 2023.